Light therapy to improve sleep and thinking in early Alzheimer’s
Part of Mental health clinical trials.
This trial studies rhythmic light therapy to help people with early Alzheimer’s or mild memory problems, especially when sleep is getting worse. If you fit the sleep and vision/medical safety requirements, the study may see whether the therapy improves sleep and thinking-related symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mild memory problems or mild Alzheimer’s (Montreal Cognitive Assessment score 17 to 25)
- You have sleep problems, based on a Pittsburgh Sleep Quality Index score above 5
- You live at home, in independent living, or in assisted living (not long-term care)
- You are not taking sleep medicines
- You do not have serious eye problems like cataracts that block vision, macular degeneration, or blindness
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how light affects sleep quality in older adults with mild memory or thinking problems. It may help find ways to improve sleep and possibly slow memory decline.
This trial tests whether a combination of 40 Hz light stimulation and cognitive (thinking) therapy can improve symptoms in people with Alzheimer’s disease. It may help by stimulating the brain and training thinking skills, while carefully checking eye and seizure history.
This study tests whether regular at-home “gamma” light and sound stimulation can help people with mild Alzheimer’s. Participants start with a month at home and are followed to see how they do during treatment.
This study tests a type of light therapy (called transcranial photobiomodulation) to see if it can help people with early-stage Alzheimer's. It involves coming to Cedars-Sinai for weekly sessions over a period of time.
This study tests a light therapy that shines near-infrared light on the head to see if it can improve memory and thinking in people with mild to moderate Alzheimer's disease. It is an early-stage trial, so the main goal is to check safety and see if the treatment shows promise.
This study tests if a near-infrared light therapy device can help improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves daily treatment sessions with the device, and a study partner must be available to help with treatment.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.